Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskNeutral

Sotera Health Company

Filed: Mar 12, 2026CIK: 0001822479
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Sotera Health Company replaced Class I director Constantine S. Mihas with Kenneth D. Krause effective March 16, 2026, due to a reduction in stockholder-designated board seats. The departure is amicable and reflects a routine board composition adjustment with no operational disagreements.

Key Takeaways

Constantine S. Mihas resigned as Class I director on March 12, 2026, effective March 16, 2026, due to reduced stockholder designation rights

Kenneth D. Krause was appointed to fill the vacant Class I director position on March 15, 2026, also effective March 16, 2026

2 more takeaways

Related Filings (1)

1 more filing from Sotera Health Company in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 12, 2026
Item5.02
CategoryExecutive Change
CIK0001822479
Accession #shc-20260312
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings